Board of Directors

Ms. Middlemore is founder and Managing Director of MC2 Business Advisors Inc. and brings over 25 years of domestic and international corporate finance experience, having advised public and private companies in a variety of industries. She was previously a partner in MNP LLP in Toronto, an advisor with PWC LLP in Toronto and in London, UK, Vice President of the board of directors of Hospice Toronto and a Sessional Lecturer at the University of Toronto, Rotman School of Management. Ms. Middlemore obtained an Honours Bachelor of Commerce degree from the University of Windsor and holds the designations of Chartered Professional Accountant, Chartered Financial Analyst and Chartered Business Valuator. She is also a member of the Institute of Corporate Directors.

Mr. Miller graduated from BCIT with an honours diploma in Mechanical Technology in 1986. At the age of 25, he purchased his first manufacturing business, Van Ingen (now Advanced Bending Technologies). He later went on to purchase IMB Industries ("IMB"), which he built into a globally successful exporter with subsidiaries in five countries, with over $100 million in revenue and 900 employees. After selling IMB in 2009, Mr. Miller continued to invest in manufacturing space in Canada and the United States and currently owns seven companies under the AdvanTec Global banner specialized in marine and industrial manufacturing with a focus on clean tech manufacturing. Additionally, Mr. Miller is a significant investor in several tech start-ups in the food processing and medical device sectors. He is also active as a volunteer director on the boards of two foundations, three not for profits and one NGO with a focus on education and health in Canada and Uganda.

Dr. Constantine (Gus) Zachos (MD, DCAPM, ABAARM) has been actively practising clinical medicine for almost 30 years. He is a diplomate with the Canadian Academy of Pain Management and Board Certified with the American Board of Anti-Aging and Regenerative Medicine. He has special interests in pain and addiction medicine and in the study of the aging process from a hormone and nutritional perspective as well as extensive experience in emergency and ambulatory medicine, particularly as it relates to clinical development. Dr. Zachos has developed extensive entrepreneurial experience in land development and in start up investment, particularly in the MedTech space as it relates to the future of healthcare both in Canada and abroad.

Mr. Charnetski is the EVP, Health System Solutions and Government Affairs for PointClickCare, a Canadian healthcare technology company. Prior to joining PointClickCare Mr. Charnetski served in the Ontario Provincial Government from 2015 to 2018 as Chief Health Innovation Strategist. He served on the Board of Waterfront Toronto from 2004 to 2011, and was Chair of that Board's Communication and Marketing Committee from 2007 to 2011. Mr. Charnetski was an attorney at Torys LLP from 1997-2004 and was a Partner at the firm from 1999 to 2004 where he practiced mergers and acquisitions, corporate finance, securities law, and was Head of the Privacy Law Group.

Dr. Kohli co-founded Cloud DX in 2014 and has 20 years experience as a practicing specialist in Internal and Critical care medicine. He has practiced at Oakville Trafalgar Memorial Hospital since 2005, and has served as Assistant Clinical Professor (Adjunct) at McMaster University since 2010. He is also founding faculty of Healthcare at Singularity University Canada. Dr. Kohli is an experienced entrepreneur and was co-founder of medical device startup Triomi Medical Innovations Inc. He's a former Canadian Space Agency (CSA) astronaut candidate, reaching the top 40, and a graduate of the International Space University where he participated in deploying experiments that flew on the International Space Station. Dr. Kohli is attending the ICD-Rotman Directors Education Program in Toronto, Ontario.

Mr. Kaul founded Cloud DX in 2014 and has nearly 30 years of experience in sales, marketing and operations leadership. Mr. Kaul previously founded Cloud Diagnostics LLC in 2009 and, following the sale of Cloud Diagnostics LLC to Biosign Technologies Inc. ("Biosign") (TSXV:BIO) in 2010, served as Executive Vice President, and later Chief Executive Officer at Biosign. Mr. Kaul holds a Bachelor of Science from the University of Alberta and an Executive Certificate in Operations Strategy from Sloan School of Management at MIT.